(MedPage Today) — A real-world study of chronic pancreatitis found GLP-1 agonists to be associated with less pain medication use and lower risks for pancreatic interventions, including major surgery. (Gastro Hep Advances)
The FDA expanded the…
Source:
www.medpagetoday.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.
